ITCTX
Price
$28.14
Change
+$0.10 (+0.36%)
Updated
Jan 17 closing price
Net Assets
6.7B
RLBCX
Price
$34.77
Change
+$0.21 (+0.61%)
Updated
Jan 17 closing price
Net Assets
240.18B
Ad is loading...

ITCTX vs RLBCX

Header iconITCTX vs RLBCX Comparison
Open Charts ITCTX vs RLBCXBanner chart's image
VY® T. Rowe Price Capital Apprec S2
Price$28.14
Change+$0.10 (+0.36%)
VolumeN/A
Net Assets6.7B
American Funds American Balanced R3
Price$34.77
Change+$0.21 (+0.61%)
VolumeN/A
Net Assets240.18B
ITCTX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ITCTX vs. RLBCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCTX is a StrongBuy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 240B vs. ITCTX (6.7B). RLBCX (1.98) and ITCTX (1.97) have matching dividends . ITCTX was incepted earlier than RLBCX: ITCTX (22 years) vs RLBCX (23 years). ITCTX has a lower initial minimum investment than RLBCX: ITCTX (0) vs RLBCX (250). ITCTX annual gain was more profitable for investors over the last year : 13.72 vs. RLBCX (11.92). RLBCX return over 5 years is better than : 28.12 vs. ITCTX (1.48).
ITCTXRLBCXITCTX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years23 years-
Gain YTD1.7351.93590%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.7B240B3%
Annual Yield % from dividends1.971.98100%
Returns for 1 year13.7211.92115%
Returns for 3 years-5.2811.58-46%
Returns for 5 years1.4828.125%
Returns for 10 years14.2953.4127%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPG67.031.53
+2.34%
TPG
NRIM78.440.73
+0.94%
Northrim BanCorp
AIV9.01-0.03
-0.33%
Apartment Investment and Management Company
GPN108.42-0.68
-0.62%
Global Payments
LEXX1.90-0.08
-3.80%
Lexaria Bioscience Corp